Skip to main content
. 2023 Oct 31;4(2):100421. doi: 10.1016/j.xops.2023.100421

Figure 5.

Figure 5

Injection frequency in patient eyes with aflibercept, bevacizumab, or ranibizumab by years of follow-up treatment (overall cohort). aMore than 9 injections includes those eyes with 10 to 13 and > 13 injections.